Jonathan A Doorn

Dr. Jonathan A Doorn

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2009 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
JRJennifer N. Rees
Jennifer N. Rees
VFVirginia R. Florang
Virginia R. Florang
LELaurie L. Eckert
Laurie L. Eckert
JDJonathan A Doorn
Jonathan A Doorn

1 July 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
DADavid G. Anderson
David G. Anderson
SMS.V. Santhana Mariappan
S.V. Santhana Mariappan
GBGarry Buettner
Garry Buettner
JDJonathan A Doorn
Jonathan A Doorn
The oxidation and toxicity of dopamine is believed to contribute to the selective neurodegeneration associated with Parkinson disease. The formation of reactive radicals and quinones greatly contributes to dopaminergic toxicity through a variety of mechanisms. The physiological metabolism of dopamine to 3,4-dihydroxyphenylacetaldehyde (DOPAL) via monoamine oxidase significantly increases its toxicity. To more adequately explain this enhanced toxicity, we hypothesized that DOPAL is capable of forming radical and quinone species upon oxidation. Here, two unique oxidation products of DOPAL are identified. Several different oxidation methods gave rise to a transient DOPAL semiquinone radical, which was characterized by electron paramagnetic resonance spectroscopy. NMR identified the second oxidation product of DOPAL as the ortho-quinone. Also, carbonyl hydration of DOPAL in aqueous media was evident via NMR. Interestingly, the DOPAL quinone exists exclusively in the hydrated form. Furthermore, the enzymatic and chemical oxidation of DOPAL greatly enhance protein cross-linking, whereas auto-oxidation results in the production of superoxide. Also, DOPAL was shown to be susceptible to oxidation by cyclooxygenase-2 (COX-2). The involvement of this physiologically relevant enzyme in both oxidative stress and Parkinson disease underscores the potential importance of DOPAL in the pathogenesis of this condition.

23 April 2009 in Chemical Research in Toxicology
Verified
Journal Article
Closed access
YJYunden Jinsmaa
Yunden Jinsmaa
VFVirginia R. Florang
Virginia R. Florang
JRJennifer N. Rees
Jennifer N. Rees
DADavid G. Anderson
David G. Anderson
SSStefan Strack
Stefan Strack
JDJonathan A Doorn
Jonathan A Doorn


1 June 2011 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
YJYunden Jinsmaa
Yunden Jinsmaa
VFVirginia R. Florang
Virginia R. Florang
JRJennifer N. Rees
Jennifer N. Rees
LMLydia M. Mexas
Lydia M. Mexas
LELaurie L. Eckert
Laurie L. Eckert
JDJonathan A Doorn
Jonathan A Doorn

1 January 2014 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
JDJonathan A Doorn
Jonathan A Doorn
VFVirginia R. Florang
Virginia R. Florang
JSJosephine H. Schamp
Josephine H. Schamp
BVBrigitte C. Vanle
Brigitte C. Vanle